Anticancer drug resistance;Resistance aux drogues anticancereuses

Presse Medicale

Volumn 25, Issue 35, 1996, Pages 1724-1730

  Benard J ^a   Rixe, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

CANCER; CANCER CHEMOTHERAPY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MULTIDRUG RESISTANCE; PHENOTYPE; REVIEW; DNA REPAIR; DRUG RESISTANCE; FORECASTING; GENETICS; PHYSIOLOGY;

DNA REPAIR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FORECASTING; HUMANS; PHENOTYPE;

EID: 0030590693     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. De Vita VT. Principles of chemotherapy. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and practice of Oncology, 4th ed, JB Lippincott, 1993 :267-93.
2. Schimcke R. Amplification des gènes et résistance aux médicaments. Pour la Science. 1981.
3. Biedler J, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: Cross-resistance, radio-autographic and cytogenetic studies. Cancer Res 1970 ; 30:1174-84.
4. Gottesman MM. How cancer cells evade chemotherapy? Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 1993 ; 53:747-54.
5. Dalton WS, Grogan TM, Meltzer PS et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of Verapamil to chemotherapy. J Clin Oncol 1989 ; 7:415-24.
6. Cole SPC, Bhardwaj G, Gerlach JH et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992 ; 258 :1650-54.
7. Muller M, Meijer C, Zaman GJR et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci 1994 ; 91:13033-7.
8. Legrand O, Perrot JY, Tang RP et al. Expression of multidrug resistance associated protein (MRP) mRNA and protein in normal peripheral and bone marrow haematopoietic cells. Br J Haematology 1996 ; 94 23-33.
9. Scheffer GL, Wijngaard PLJ, Flens MJ et al. The drug resistance-related protein LRP is the human major vault protein. Nature 1995 ; 1:578-82.
10. Brock I, Hipfner DR, Nielsen BS et al. Sequential coexpression of the multidrug resistance genes MRP and mdm1 and their products in VP-16 (etoposide)-selected H69 smallcell lung cancer cells. Cancer Res 1995 ; 55:459-62.
11. Izquierdo MA, Van der Zee A, Vermorken J et al. The drug resistance-associated marker LRP predicts poor response to platinum-alkylating chemotherapy and outcome in advanced ovarian carcinoma. J Natl Cancer Inst 1995 ; 87:1230-7.
12. Duguet M, Riou J-F. De la topologie de l'ADN aux médicaments antibiotiques et anticancéreux. Medecine Sci 1994 ; 10:962-72.
13. Hendricks CB, Rowinsky EK, Grochow LB, Donehower RC, Kaufmann SH. Effect of P-glycoprotein expression on the accumulation and cytotoxicity of topotecan (SKF 104864), a new camptothecin analogue. Cancer Res 1992 ; 52 :2268-78.
14. Leteurtre F, Jujimore A, Tanizawa A et al. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. J Biol Chem 1994 ; 269:28702-7.
15. Kramer RA, Zakher J, Kim G. Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 1988 ; 241:694-7.
16. Moscow JA, Fairchild CR, Madden MJ et al. Expression of anionic glutathione -S- transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 1989 ; 49:1422-8.
17. Zhen W., Link CJ, O'Connor PM et al. Increased gene-specific repair of cisplatin interstrand adducts in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol 1992 ; 12:3689-98.
18. Sancar A. Excision repair in mammalian cells. J Biol Chem 1995 ; 270 :15915-18.
19. Rixe O, Ortuzar W, Alvarez M, Parker R, Reed E, Paull K, Fojo T. Oxaliplatin and cisplatin: spectrum of activity in drug resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen Panel. 1996 (sous presse).
20. Cabral R, Brady RC, Schibler MJ. A mechanism of cellular resistance that interfere with microtubule assembly. Annals of NY Acad Sci 1992 : 745-56.
21. Jacks T, Weinnberg R. Cell-cycle control and its watchman. Nature 1996 ; 381:643-4.
22. Waldman T, Lengauer C, Kinzler K, Vogelstein B. Uncoupling of S phase and mitosis by anticancer agents in cells lacking p21. Nature 1996 ; 381 :713-6.
23. Lowe S, Ruley HE, Jacks T, Houssman D. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993 ; 74:957-67.
24. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992 ; 11:121-39.
25. Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Various methods of analysis of mdr-1/P-Glycoprotein in human colon cancer cell lines. J Natl Cancer Inst 1992 ; 84:711-16.
26. Perrot JY, Faussat AM, Zhou DC et al. Evaluation multicentrique du phénotype MDR dans les leucémies : analyse intermédiaire de l'expérience française. Bull Cancer 1996 ; 83:634-40.
27. Nishiyama K, Shirahama T, Yoshimuru A et al. expression of the multidrug transponer, P-glycoprotein, in renal and transitionnal cell carcinomas. Cancer 71:3611-19.
28. Naito S, Sakamoto N, Kotoh S et al. Expression of P-glycoprotein and multidrug resistance in renal cell carcinoma. Eur Urol 1993 ; 24:156-60.
29. List AF, Spier C, Greer J et al. Phade I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 1993 ; 11: 1652-60.
30. Vreugdenhil G, Raemackers JMM, Van Dijke BJ et al. Itraconazole and multidrug resistance: possible effects on remission rate and disease-free survival in acute leukemia. Ann Hematol 1993 ; 67:107-9.
31. Wilson WH, Bates SE, Fojo AT et al. Contolled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. J Clin Oncol 1995 ; 13:1995-2004.
32. Ferrandis E, Da Silva J, Riou G, Bénard J. Co-activation of the MYCN and MDR1 genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res 1994 ; 54:2256-61.
33. Williams G, Smith C. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993 ; 74:777-9.